The Predictive Role of Fetal Growth for Placental Invasion Anomalies in Placenta Previa

Abstract

Objective

To evaluate the predictive role of fetal percentile for placental invasion anomalies in placenta previa cases. Study Design: Retrospective studyPlace & Duration of the Study: Training and Research Hospital, January 2018 and December 2023

Methodology

A total of 298 placenta previa cases was divided into two groups: PAS (placenta accreta spectrum)-positive placenta previa (n=98) and PAS-negative placenta previa (n=200). Then PAS-positive placenta previa cases were divided into two subgroups: placenta increta-accreta (n=59) and placenta percreta (n=39). Sociodemographic findings, obstetric features, fetal percentile measurements between 22 and 28 gestational weeks and perioperative characteristics of patients were recorded and compared between groups.

Results

Fetal percentile was significantly lower in PAS-positive placenta previa cases as compared to PAS-negative placenta previa cases (p<0.001). Moreover, fetal percentile≤52.5 discriminated PAS-positive placenta previa cases from PAS-negative placenta previa cases with 75.51% sensitivity and 51.5% specificity (p<0.001, AUC=0.654). In multivariate analysis, a fetal percentile of 52.5 and below increased the risk of PAS by approximately 4 times (Hosmer–Lemeshow p=0.101, model p<0.001). No significant difference was detected between placenta percreta and placenta accreta-increta groups in terms of fetal percentile (p=0.224).

Conclusion

Fetal percentiles calculated between 22 and 28 gestational weeks could discriminate PAS-positive placenta previa cases from PAS-negative placenta previa cases, although it had no role in discriminating placenta percreta from accreta and increta cases. Therefore, the evaluation of fetal percentile in placenta previa cases can be considered as a supportive finding in the prediction of invasion anomaly although it does not determine the depth of invasion.

Keywords

accreta - fetal percentile - increta - percreta - placental invasion

Publikationsverlauf

Eingereicht: 04. Februar 2025

Angenommen nach Revision: 02. Mai 2025

Artikel online veröffentlicht:
16. Juni 2025

• References

• 1 Sahu SA, Shrivastava D. Maternal and perinatal outcomes in placenta previa: A comprehensive review of evidence. Cureus 2024; 16: e59737
• 2 Lipa M, Goławski K, Kosiński P. et al. Placenta praevia – does it really affect intrauterine fetal growth?. J Matern Fetal Neonatal Med 2022; 35: 3898-3902
• 3 Ozkose ZG, Oglak SC, Behram M. et al. Maternal serum cripto-1 levels in pregnancies complicated with placenta previa and placenta accreta spectrum (PAS). J Coll Physicians Surg Pak 2022; 32: 1570-1575
• 4 Ozgen G, Aydin GA. Effectiveness of intrauterine Bakri balloon tamponade for placenta previa and placenta accreta spectrum. J Coll Physicians Surg Pak 2020; 30: 707-712
• 5 Giouleka S, Tsakiridis I, Chanioti ER. et al. Placenta accreta spectrum: A comprehensive review of guidelines. Obstet Gynecol Surv 2024; 79: 366-381
• 6 Tersigni C, Di Simone N, Lucchetti D. et al. Shedding of syncytiotrophoblast-derived extracellular vesicles is increased in placenta previa and accreta spectrum. Reprod Sci 2024; 31: 2043-2048
• 7 Flo K, Widnes C, Vårtun Å. et al. Blood flow to the scarred gravid uterus at 22–24 weeks of gestation. BJOG 2014; 121: 210-215
• 8 Hannon T, Innes BA, Lash GE. et al. Effects of local decidua on trophoblast invasion and spiral artery remodeling in focal placenta creta – an immunohistochemical study. Placenta 2012; 33: 998-1004
• 9 Harper LM, Odibo AO, Macones GA. et al. Effect of placenta previa on fetal growth. Am J Obstet Gynecol 2010; 203: 330.e1-5
• 10 Bartels HC, Walsh JM, O'Connor C. et al. Placenta accreta spectrum ultrasound stage and fetal growth. Int J Gynaecol Obstet 2023; 160: 955-961
• 11 Agarwal N, Papanna R, Sibai BM. et al. Evaluation of fetal growth and birth weight in pregnancies with placenta previa with and without placenta accreta spectrum. J Perinat Med 2025; 53: 9-14
• 12 Weiner E, Miremberg H, Grinstein E. et al. The effect of placenta previa on fetal growth and pregnancy outcome, in correlation with placental pathology. J Perinatol 2016; 36: 1073-1078
• 13 Jauniaux E, Dimitrova I, Kenyon N. et al. Impact of placenta previa with placenta accreta spectrum disorder on fetal growth. Ultrasound Obstet Gynecol 2019; 54: 643-649
• 14 Sadiku E, Sun L, Macgowan CK. et al. Advanced magnetic resonance imaging in human placenta: insights into fetal growth restriction and congenital heart disease. Front Cardiovasc Med 2024; 11: 1426593
• 15 Balayla J, Desilets J, Shrem G. Placenta previa and the risk of intrauterine growth restriction (IUGR): a systematic review and meta-analysis. J Perinat Med 2019; 47: 577-584
• 16 Ananth CV, Demissie K, Smulian JC. et al. Relationship among placenta previa, fetal growth restriction, and preterm delivery: a population-based study. Obstet Gynecol 2001; 98: 299-306
• 17 Brar HS, Platt LD, DeVore GR. et al. Fetal umbilical velocimetry for the surveillance of pregnancies complicated by placenta previa. J Reprod Med 1988; 33: 741-744
• 18 Yeniel AO, Ergenoglu AM, Itil IM. et al. Effect of placenta previa on fetal growth restriction and stillbirth. Arch Gynecol Obstet 2012; 286: 295-298
• 19 Wolf EJ, Mallozzi A, Rodis JF. et al. Placenta previa is not an independent risk factor for a small for gestational age infant. Obstet Gynecol 1991; 77: 707-709
• 20 Detlefs SE, Carusi DA, Modest AM. et al. The association between placenta accreta spectrum severity and incidence of small for gestational age neonates. Am J Perinatol 2023; 40: 9-14